Arming Bodies with CRISPR to Fight Huntington’s Disease and ALS – MIT Technology Review
MIT Technology Review |
Arming Bodies with CRISPR to Fight Huntington’s Disease and ALS
MIT Technology Review To do it, Gene Yeo, the company’s cofounder and a professor of cellular and molecular medicine at the University of California, San Diego, School of Medicine, is repurposing CRISPR to go after a different target: RNA, the messenger molecule involved in … Gene-editing technology repairs mutation for muscular dystrophyDigital Journal |
Prostate Cancer News Today |
Endocyte Pursuing Phase 3 Trial of 177Lu-PSMA-617 in Metastatic PC
Prostate Cancer News Today “With the exception of a very targeted effort to generate proof-of-concept data for our CAR T-cell program, we will focus our resources on the development of 177Lu-PSMA-617. We will explore out-licensing opportunities for all other development programs … |
Drug Discovery & Development |
Poseida Therapeutics Presents Preclinical Solid Tumor Data for P-PSMA-101, a CAR–T Therapy Predominantly …
Markets Insider This preclinical study demonstrated that Poseida’s advanced CAR–T cell therapy could completely eliminate solid tumors in a previously incurable preclinical model of prostate cancer, and was selected for oral presentation today at the 24th Prostate … Endocyte Pursuing Phase 3 Trial of 177Lu-PSMA-617 in Metastatic PCProstate Cancer News Today |
Renal and Urology News |
Liquid biopsies predict response to immunotherapy
Healio “Immune checkpoint inhibitors, a class of immunotherapy, are transforming cancer treatment; however, overall only about 20% of patients respond to these drugs, and the drugs sometimes have significant side effects,” Razelle Kurzrock, MD, director of … Hypermutated ctDNA: A Marker of Checkpoint Inhibitor Response?Renal and Urology News |
Daily Mail |
Gene therapy helps boys with disease in Lorenzo’s Oil | Daily Mail …
Daily Mail The fledgling field of gene therapy has scored another win: An experimental treatment seemed to help boys with the inherited nerve disease featured in the … Bluebird’s gene therapy shows promise in keeping lethal Lorenzo’s …Endpoints News Gene Therapy May Be Breakthrough for Boys With ‘Lorenzo’s Oil …HealthDay |
CBS News |
Gene therapy helps boys with rare nerve disease seen in “Lorenzo’s Oil”
CBS News The fledgling field of gene therapy has scored another win: An experimental treatment seemed to help boys with the inherited nerve disease featured in the movie “Lorenzo’s Oil.” Fifteen of the 17 boys treated in a study had no major disability two … |